Novartis and Roche have been closely linked since the former took a stake in its rival in 2001. Roche’s recent misfortune and low share price opened the door for a $440 billion tie-up. However, getting the deal over the line will be tricky, argues Aimee Donnellan.
Keep up with the latest news from around the world: [ Ссылка ]
#News #Reuters #newsfeed #BVPredicts #breakingviews #novartis #roche #pharmaceutical
Subscribe: [ Ссылка ]
Reuters brings you the latest business, finance and breaking news video from around the globe. Our reputation for accuracy and impartiality is unparalleled.
Get the latest news on: [ Ссылка ]
Follow Reuters on Facebook: [ Ссылка ]
Follow Reuters on Twitter: [ Ссылка ]
Follow Reuters on Instagram: [ Ссылка ]
